Live feed06:35:50·663dNEWSReleasevia QuantisnowTuHURA Biosciences And Kintara Therapeutics Announce Agreement For Potential Acquisition Of Kineta's Anti-VISTA AntibodyByQuantisnow·Wall Street's wire, on your screen.KA· Kineta Inc.KTRA· Kintara Therapeutics Inc.Health Care